sangamo biosciences inc (GBY:Frankfurt)

Executive Profile*

Background*

Mr. H. Ward Wolff has been an Executive Vice President and Chief Financial Officer of Sangamo Biosciences Inc. since December 2007 and serves as its Principal Accounting Officer. Mr. Wolff oversees Sangamo's administrative, financial and business development activities and operations. He has over 25 years of financial experience. He served as Chief Financial Officer and Senior Vice President of Finance of Abgenix, Inc. from September 13, 2004 to April 2006 and served ... as its Principal Accounting Officer. From July 2002 to December 2003, Mr. Wolff served as Chief Financial Officer of QuantumShift. From April 1998 to January 2002, he served as Senior Vice President and Chief Financial Officer of DoubleTwist, Inc. From July 1995 to 1998, he served as Chief Financial Officer of Premenos Technology Corp. and also served as its Senior Vice President of Finance and Administration from July 1996 to 1998. Mr. Wolff served as Senior Vice President of Finance and Administration of Premenos Corporation at Premenos Technology Corp. since July 1996 and also served as its Chief Financial Officer. Mr. Wolff served as Senior Vice President of Finance and Chief Financial Officer of Nuvelo, Inc. from July 19, 2006 to August 14, 2007 and served as its Principal Accounting Officer since September 1, 2006. From 1974 to 1985, Mr. Wolff served in numerous positions with Price Waterhouse as a Certified Public Accountant, including Senior Audit Manager. He has been an Independent Director of Portola Pharmaceuticals, Inc. since November 2007. Mr. Wolff served as a Director of Sangamo Biosciences Inc. from June 2006 to December 2007. He served as a Director of MAP Pharmaceuticals, Inc. from March 25, 2008 to March 1, 2013. From 1985 to 1992, he served as an Executive Director of Russell Reynolds Associates, Inc. Mr. Wolff received a BA degree in Economics from the University of California at Berkeley and an MBA degree from Harvard Business School.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
GBY:GR	€6.09 EUR	+0.036

COMPETITOR COMPENSATION